氧化在Poloxamer 188的心脏保护中的作用
Zhu Li1, Matthew B Barajas1,2, Takuro Oyama1
1Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Cells
|July 11, 2025
概括
波洛克萨默188通过稳定膜来保护心脏细胞免受伤害. 这种保护需要氧化 (NO),并且在与内皮细胞 (EC) 结合时效果最好.
科学领域:
- 心血管科学 心血管科学
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 已知Poloxamer 188 (P188) 通过稳定细胞膜,可以预防心肌缺血/反 (I/R) 损伤.
- 内皮细胞 (ECs) 可以通过细胞与细胞相互作用保护心肌细胞 (CMs),特别是防止缺氧/低氧化 (HR) 损伤.
研究的目的:
- 调查P188保护HR受伤的机制,特别是探讨氧化 (NO) 的作用.
- 确定EC是否对于P188介导的保护是必要的,并检查P188,EC和NO之间的相互作用.
主要方法:
- 与老鼠冠状动脉ECs建立的共同培养系统在老鼠CMs上方的插件中.
- 细胞受到低氧/低氧化 (HR) 或正常氧的作用.
- 治疗包括P188 (300μM),N(ω) -nitro-L-arginine甲基 (LNAME,一种NO合成酶抑制剂,40mM) 或载体.
- 乳酸脱酶释放和CM中的过载被测量为损伤指标.
主要成果:
- 单独P188可将HR诱导的损伤标志物 (乳酸脱酶释放和过载) 降低16-18%.
- 当与ECs共同培养时,P188提供了增强的保护 (22-25%).
- LNAME完全取消了P188的保护作用,表明没有依赖性.
- 在测试密度下,单独使用EC并没有提供显著的保护.
结论:
- 波洛克萨默188需要氧化 (NO) 来保护心肌细胞免受低氧/低氧化损伤.
- 虽然内皮细胞增强了P188的保护作用,但所涉及的NO可能不完全来自内皮细胞.
- 这项研究揭示了P188介导心脏保护的关键NO依赖途径.
相关概念视频
Nitric Oxide Signaling Pathway
5.2K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.2K
Antianginal Drugs: Nitrates and β-Blockers
761
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
761
Antihypertensive Drugs: Vasodilators
649
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
649
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
702
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
702
Coronary Artery Disease II: Pathophysiology
40
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
40
Coronary Artery Disease V: Interprofessional Care
38
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
38


